Ontology highlight
ABSTRACT:
SUBMITTER: Chilmonczyk MA
PROVIDER: S-EPMC7940552 | biostudies-literature | 2021 Mar
REPOSITORIES: biostudies-literature
Chilmonczyk Mason A MA Doron Gilad G Kottke Peter A PA Culberson Austin L AL Leguineche Kelly K Guldberg Robert E RE Horwitz Edwin M EM Fedorov Andrei G AG
Biotechnology journal 20201012 3
Nascent advanced therapies, including regenerative medicine and cell and gene therapies, rely on the production of cells in bioreactors that are highly heterogeneous in both space and time. Unfortunately, advanced therapies have failed to reach a wide patient population due to unreliable manufacturing processes that result in batch variability and cost prohibitive production. This can be attributed largely to a void in existing process analytical technologies (PATs) capable of characterizing the ...[more]